project id: TCGA-STAD; case submitter id: TCGA-RD-A8N9; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.19; rna integrity number: 7.1; age at index: 63; days to birth: -23059; ethnicity: not hispanic or latino; gender: female; race: asian; vital status: Alive; year of birth: 1946; age at diagnosis: 23059; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage II; ajcc pathologic t: T2; ajcc staging system edition: 6th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1083.0; icd 10 code: C16.0; last known disease status: not reported; morphology: 8145/3; primary diagnosis: Carcinoma, diffuse type; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cardia, NOS; synchronous malignancy: No; tissue or organ of origin: Cardia, NOS; tumor grade: Not Reported; year of diagnosis: 2009; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; weight: 30.0; composition: Not Reported; days to collection: 1644; days to sample procurement: 0; initial weight: 100.0; portion submitter id: TCGA-RD-A8N9-01A-12; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 10.0; percent tumor cells: 80.0; percent tumor nuclei: 90.0;